kabutan

D.Western Therapeutics Institute, The Current Fiscal Year's Net Income to Narrow

Mon Feb 10, 2025 3:30 pm JST Earnings

4576 D.Western Therapeutics Institute, Inc. 【J-GAAP】

Earnings Report

D.Western Therapeutics Institute, Inc. <4576> [TSE Growth] announced its financial results after the market closed on February 10th (15:30). The consolidated net loss for the fiscal year ending December 2024 expanded to a loss of 1.29 billion yen (compared to a loss of 0.81 billion yen in the previous period), but it is expected to shrink to loss of 0.68 billion yen for the fiscal year ending December 2025. This will mark the sixth consecutive term of losses.

In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 0.56 billion yen (compared to a loss of 0.36 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -296.5% in the same period last year to -456.9%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 448 -305 -295 -429 -14.5 0 Feb 13, 2023 J-GAAP
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
YoY +10.0% -51.5% -54.3% -58.9% -43.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 471 -1,209 -1,228 -1,290 -31.0 0 Jan 16, 2025 J-GAAP
Dec, 2024 Results 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Revision Rate 0.0% 0.0% 0.0% 0.0% -18.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 223 -449 -459 -520 -16.2 0 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 Guidance 0 Feb 10, 2025 J-GAAP
YoY

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 428 -798 -796 -812 -25.6 0 Feb 9, 2024 J-GAAP
Dec, 2024 471 -1,209 -1,228 -1,290 -36.7 0 Feb 10, 2025 J-GAAP
Dec, 2025 Guidance 400 -670 -680 -680 -14.9 0 Feb 10, 2025 J-GAAP
YoY -15.1% +44.6% +44.6% +47.3% +59.5%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 115 -341 -343 -369 -11.6 -296.5 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 104 -318 -320 -320 -10.0 -305.8 May 13, 2024 J-GAAP
Apr - Jun, 2024 119 -131 -139 -200 -6.2 -110.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 125 -198 -206 -207 -6.2 -158.4 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 123 -562 -563 -563 -16.0 -456.9 Feb 10, 2025 J-GAAP
YoY +7.0% -64.8% -64.1% -52.6% -38.0%

Related Articles